POS-322 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN THE AMERICAS AND THE ASIA-PACIFIC REGION USING MICROSIMULATION MODELLING

• J.J. GARCIA SANCHEZ,
• N. Tangri,
• A. Abdul Sultan,
• M.C. Batista,
• C. Cabrera,
• S. Chadban,
• G. Chertow,
• E. Kanda,
• G. Li,
• S. Nolan,
• L. Retat,
• S. Xin,
• L. Webber,
• J. Wish,
• M. Xu

Affiliations

J.J. GARCIA SANCHEZ

AstraZeneca, Health Economics, Cambridge, United Kingdom

N. Tangri

University of Manitoba, Chronic Disease Innovation Center, Winnipeg, Canada

A. Abdul Sultan

AstraZeneca, Epidemiology, Cambridge, United Kingdom

M.C. Batista

Hospital Israelita Albert Einstein, Nephrology, São Paulo, Brazil

C. Cabrera

AstraZeneca, Epidemiology & Evidence Excellence, Gothenburg, Sweden

S. Chadban

Royal Prince Alfred Hospital, Renal Medicine, Sydney, Australia

G. Chertow

Stanford University School of Medicine, Division of Nephrology, Palo Alto, United States

E. Kanda

Kawasaki Medical University, Medical Science, Okayama, Japan

G. Li

Sichuan Academy of Medical Science, Nephrology, Chengdu, China

S. Nolan

AstraZeneca, Diabetes, Cambridge, United Kingdom

L. Retat

HealthLumen, Microsimulation modelling, London, United Kingdom

S. Xin

West China Hospital- Sichuan University, Epidemiology- Evidence-Based Medicine- Disease Management and Healthcare Policy, Chengdu, China

L. Webber

HealthLumen, Microsimulation modelling, London, United Kingdom

J. Wish

Indiana University School of Medicine, Nephrology, Indianapolis, United States

M. Xu

HealthLumen, Microsimulation modelling, London, United Kingdom